VRC01抗体によるHIV-1の広範で強力な中和のための構造的基礎
Tongqing Zhou1, Ivelin Georgiev, Xueling Wu
1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892, USA.
まとめ
広く中和する抗体VRC01は,ヒト免疫不全ウイルス (HIV) gp120封筒を標的とする. そのユニークな結合機構は,CD4受容体の相互作用を模倣し,HIV-1の効果的な中和のためにウイルス防御を克服します.
科学分野:
- 構造生物学 構造生物学とは
- 免疫学 免疫学とは
- ウイルス学 ウイルス学 ウイルス学
背景:
- HIV-1 gp120エンベロップグリコタンパク質に対する抗体は,感染中に生成されます.
- VRC01は強力な抗体で,様々なHIV-1株を広く中和することができます.
研究 の 目的:
- HIV-1 gp120コアと複合したVRC01の結晶構造を決定する.
- VRC01が広範なHIV-1中和を達成するメカニズムを解明する.
主な方法:
- X線結晶学でVRC01-gp120複合体の構造を決定する.
- gp120とのVRC01の相互作用の分析,CD4結合部位ミミクリに焦点を当てた.
主要な成果:
- VRC01は部分的にgp120.pとCD4受容体の相互作用を模倣する.
- VRC01の指向は脆弱な部位を標的とし,グリカンとコンフォメーションマスクを克服します.
- VRC01は,gp120の認識のために,著しく変化した免疫グロブリンV遺伝子領域を使用しています.
結論:
- 部分的なCD4ミミクリと広範な親和性成熟により,VRC01はHIV-1を中和させることができます.
- この発見は,HIV-1の治療に有効な抗体を設計するための洞察を提供します.
さらに関連する動画
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
関連する概念動画
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
